Literature DB >> 4601666

Response and survival of patients with metastatic neuroblastoma after combination chemotherapy with adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and vincristine (NSC-67574).

M Gasparini, F F Bellani, R Musumeci, G Bonadonna.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4601666

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


× No keyword cloud information.
  4 in total

1.  Blood and neoplastic diseases. Solid tumours in children.

Authors:  J S Malpas; J E Freeman
Journal:  Br Med J       Date:  1974-12-21

2.  Chemotherapy of advanced neuroblastoma: does adriamycin contribute?

Authors:  J Ninane; J Pritchard; J S Malpas
Journal:  Arch Dis Child       Date:  1981-07       Impact factor: 3.791

3.  Treatment of advanced neuroblastoma with high-dose melphalan and autologous bone marrow transplantation.

Authors:  O Hartmann; C Kalifa; E Benhamou; C Patte; F Flamant; C Jullien; F Beaujean; J Lemerle
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma.

Authors:  J Pritchard; T J McElwain; J Graham-Pole
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.